Non-Heme Iron Panel in Patients with Anemia and Chronic Kidney Disease


The objective of the study: to improve the quality of diagnosis of anemia of renal origin by studying the non-heme iron state in patients with different stages of chronic kidney disease (CKD). Material and methods: the study included 79 patients with CKD (28 – male, 51 – female) 33-72 years old. The patients were divided into two groups: group I included 24 patients without anemia, group II included 55 patients with anemia. Patients of group II were divided into 3 subgroups: 31 patients– with mild degree of anemia (subgroup 1), 18 patients – moderate degree (subgroup 2), 6 patients – severe degree (subgroup 3). The control group consisted of 20 healthy people. A complete hematology panel, urine tests, kidney ultrasound, serum urea and creatinine levels, glomerular filtration rate (GFR) by MDRD were performed. The serum iron levels, total and latent serum iron ability by ferritin and transferrin levels were measured. Results: among patients CKD of II-III stages in 67% of cases and CKD of IV-V stages in 33% of cases were revealed. Anemia of mild degree was revealed in 56% of cases; moderate degree in 33% and severe degree in 11% of cases. It was found that in the case of anemia of renal origin serum creatinine and urea levels increased, and decreased GFR, serum hemoglobin, hematocrit, iron, transferrin, and ferritin levels deceased also. Intensive change of these parameters was the most pronounced in patients with severe anemia. This was confirmed by exiting positive correlations between hemoglobin and serum iron and transferrin levels. Conclusions: iron deficiency in the body is an important branch of the anemia pathogenesis in patients with CKD. For the diagnosis of anemia and its severity degree we should  consider not only hemoglobin levels but the indicators of non-heme iron status in the patients with CKD. Decreasing serum iron, transferrin and ferritin levels determine severity of anemia and CKD. The lowest non-heme iron levels are typical for patients with CKD of IV-V stages and severe anemia.


Vatutina N.T., Kalinkin N.V., Smirnov A.S. The role of iron in the human body. Visnyk Kharkivskogo natsionalnogo universutety imeni V. N. Karazina 2012; 1024:74–80.

Vydyborets S.V. Mechanisms of iron deficiency formation and modern approaches to prescription of oral iron drugs. J Reproduct Еndocr 2013; 3(11):10–17

Pyrih L.A. Clinical Nephrology. Kyiv, Zdorovia. 2004: 450–526.

Katerenchuk I.P., Yarmola T.I. Chronic kidney disease. Kyiv. 2012; 148.

Megid E.N., Bello E.N. Chronic kidney disease: the global challenge. J Lancet 2005; 365: 331– 340.

McClellan W.M., Flanders W.D., Langston R.D. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Sue. Nephrology. 2002; 13: 1926–1936.

Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. J Kidney inter. 2012; 2:279–335.

Hsu C.Y., McCulloch C.E., Curhan G.C. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrology. 2002; 13: 504.

Weiss G., Goodnough L.T. Anemia of Chronic Disease. N Engl J Med. 2005; 352: 1011–23.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Download data is not yet available.